![](/img/cover-not-exists.png)
Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human Apo2L/TRAIL (Dulanermin), a Dual Proapoptotic Receptor (DR4/DR5) Agonist
Subbiah, V., Brown, R. E., Buryanek, J., Trent, J., Ashkenazi, A., Herbst, R., Kurzrock, R.Volume:
11
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-12-0358
Date:
November, 2012
File:
PDF, 1.15 MB
english, 2012